{"schema_version":"secwatch.filing_event.v1","accession":"0001367644-24-000176","form_type":"8-K","ticker":"EBS","cik":"0001367644","company_name":"Emergent BioSolutions Inc.","filed_at":"2024-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.267415+00:00","generated_at":"2026-05-30T04:24:42.904876+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Emergent BioSolutions Q3 2024 revenue $293.8M (+9% YoY), net income $114.8M, raises FY2024 guidance","bullets":["Q3 2024 total revenues $293.8M, up 9% year-over-year; net income $114.8M vs loss of $263.4M in Q3 2023.","Adjusted EBITDA surged 432% to $105.3M; company raises FY2024 revenue guidance to $1.065B-$1.125B.","Entered new $250M term loan with OHA Agency and $100M asset-backed loan with Wells Fargo.","Completed asset sales: RSDL product to SERB for $75M, Baltimore-Camden site for $35M, Canton warehouse for $7M.","Received $50M from Janssen contractual dispute resolution and $30M milestone from Bavarian Nordic."],"urls":{"canonical":"https://secwatch.observer/filing/0001367644-24-000176","json":"https://secwatch.observer/filing/0001367644-24-000176.json","markdown":"https://secwatch.observer/filing/0001367644-24-000176.md","text":"https://secwatch.observer/filing/0001367644-24-000176.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367644/000136764424000176/0001367644-24-000176-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367644/000136764424000176/ebs-20241106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:24:42.904876+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}